This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Nov 8;296(18):2205.

doi: 10.1001/jama.296.18.2205-a.

Investigation, explanation, and apology for incomplete and erroneous disclosures

Eric L Matteson, Tim Bongartz

PMID: 17090765
DOI: 10.1001/jama.296.18.2205-a

Comment

Investigation, explanation, and apology for incomplete and erroneous disclosures

Eric L Matteson et al. JAMA. 2006.

. 2006 Nov 8;296(18):2205.

doi: 10.1001/jama.296.18.2205-a.

Authors

Eric L Matteson, Tim Bongartz

PMID: 17090765
DOI: 10.1001/jama.296.18.2205-a

No abstract available

PubMed Disclaimer

Comment on

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.
Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Bongartz T, et al. JAMA. 2006 May 17;295(19):2275-85. doi: 10.1001/jama.295.19.2275. JAMA. 2006. PMID: 16705109

Publication types

Actions
Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems